Ligunza is the trade name and generic name of Erythromycin Succinate Tablets. It belongs to the class of macrolide antibiotics and has antibacterial activity against staphylococcus spp, streptococcus spp and gram-positive bacilli. Side effects after taking the drug include fatigue, nausea and vomiting, abdominal pain and diarrhea, skin rash, jaundice, cardiac arrhythmia, oral or vaginal candida infection. Erythromycin Succinate Tablets can be used as an alternative medicine for penicillin allergy, treatment of acute tonsillitis, acute pharyngitis, sinusitis, scarlet fever, cellulitis, diphtheria, gas gangrene, anthrax, tetanus, syphilis and so on. It is also used in the treatment of legionellosis, mycoplasma and chlamydia pneumonia, genitourinary infections, conjunctivitis, enteritis, whooping cough, recurrence of rheumatic fever, and infective endocarditis. Large doses of this product, especially in people with liver and kidney disease or elderly patients, may cause hearing loss. Allergic reactions after taking the drug are manifested as drug fever, skin rash and eosinophilia. Erythromycin ethylsuccinate tablets or other erythromycin preparations allergy, chronic liver disease patients, liver function impairment and pregnant women are prohibited, breastfeeding women should be used with caution or suspend breastfeeding. If you need to use Erythromycin Succinate Tablets, please consult a professional doctor, follow the doctor’s instructions, reasonable use of medication.